Cytorum
cytorum.com
Actively hiring
Drug Discovery
Biotechnology
Data & Analytics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$150k
5 rounds on record
Latest round
$150k
Venture round · Mar 2022 · 4 yr ago
Team
11-50
employees, estimated range
Grants
$3.6M
4 grants · CORDIS
The money's age
Long since its last round
54 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 1, 2025
Won a grant $1.2M · CORDIS
Jul 18, 2023
Won a grant $1.9M · CORDIS
May 4, 2022
Won a grant $251k · CORDIS
Mar 10, 2022
Won a grant $254k · CORDIS
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Aug 2025 | $1.2M | — | CORDIS |
| Grant | Jul 2023 | $1.9M | — | CORDIS |
| Grant | May 2022 | $251k | — | CORDIS |
| Venture round | Mar 2022 | $150k | — | SEC Form D |
| Grant | Mar 2022 | $254k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Cytorum, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Peter KrutzikExecutive Officer, DirectorSEC Form D
Tom WehrmanExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Bioqore
backs Enveda Biosciences
Similar startupsby what they do, their industry and backers
KiloGen Therapeutics specializes in proximity pharmacology, molecular glues, targeted protein degradation (TPD), biotechnology, drug…
Bioqore pairs proprietary Bayesian AI with an automated wet lab to find robust, scalable process conditions for biologics, delivered as CMC…
0 About Us AAX Biotech AB is a research-driven biotech company with proprietary technologies that solve unmet needs in the development of…
Xylo is pioneering next-generation therapeutics designed to rewire neural circuits and restore brain function. Discover our innovative…
Streamline discovery with our integrated drug discovery platform, blending AI, physics-based tools, and wet lab for unparalleled…
From Code to Cure: Etcembly combines cutting-edge artificial intelligence and bioengineering to accelerate therapeutic innovation and…
Overview
We provide next generation fluorescence, spectral, and mass cytometry services. Project design, wet lab assay development, and advanced data analytics.
People
Peter Krutzik
Executive Officer, Director
Tom Wehrman
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Santa Clara
United States
HQ
Contact us
10-50 est. staff
3350 Scott Blvd, Suite 6001, Santa Clara, CA 95054